Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 21, 2021
SARS-CoV-2 and pathological matrix remodeling mediatorsImen Guizani, Nesrine Fourti, Wiem Zidi, et al.
Clinical Laboratory|May 25, 2016
Abnormal Circulating Levels of Metalloproteinase and Their Inhibitor in Hypertensive PatientsYosra Zayani, Monia Allal-Elasmi, Wiem Zidi, et al.
International Journal of Immunogenetics|February 13, 2020
MICA-129 Met/Val polymorphism could be a genetic biomarker for Familial Breast Cancer in the Tunisian populationNesrine Ouni, Arij Ben Chaaben, Fayza Ayari, et al.
Molecular Biology Reports|October 11, 2018
Association of matrix metalloproteinase 3 and endogenous inhibitors with inflammatory markers in mitral valve disease and calcificationSonia Aloui, Wiem Zidi, Sana Ouali, et al.
Clinical Laboratory|December 9, 2015
Metabolic Syndrome, Independent Predictor for Coronary Artery DiseaseWiem Zidi, Monia Allal-Elasmi, Yosra Zayani, et al.
Molecular Biology Reports|August 12, 2022
Matrix metalloproteinase 3 and 9 as genetic biomarkers for the occurrence of cardiovascular complications in coronary artery disease: a prospective cohort studyImen Guizani, Wiem Zidi, Yosra Zayani, et al.
Molecular Biology Reports|June 21, 2019
Matrix metalloproteinase-3 predicts clinical cardiovascular outcomes in patients with coronary artery disease: a 5 years cohort studyImen Guizani, Wiem Zidi, Yosra Zayani, et al.
Cytokine|July 26, 2016
Inflammations mediators and circulating levels of matrix metalloproteinases: Biomarkers of diabetes in Tunisians metabolic syndrome patientsYosra Zayani, Nargess El Golli, Wiam Zidi, et al.
Pageof 1